Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015; Preclinical Evidence for Treatment

被引：0

作者：

Kuribayashi, Kozo ^{[1
]}

Ieki, Ryuji ^{[1
]}

Otsuki, Taiichiro ^{[1
]}

Gotoh, Akinobu ^{[2
]}

Tanaka, Akito ^{[3
]}

Nishizaki, Tomoyuki ^{[4
]}

Nakano, Takashi ^{[1
]}

机构：

[1] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan

[2] Hyogo Coll Med, Inst Adv Med Sci, Lab Cell & Gene Therapy, Nishinomiya, Hyogo 6638501, Japan

[3] Hyogo Univ Hlth Sci, Adv Med Res Ctr, Lab Chem Biol, Kobe, Hyogo, Japan

[4] Hyogo Coll Med, Dept Physiol, Nishinomiya, Hyogo 6638501, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

Naftopidil; anticancer drug; apoptosis; Malignant pleural mesotelioma (MPM);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI25.03

引用

页码：S352 / S352

页数：1

共 45 条

[1] POTENT ANTI-MESOTHELIOMA ACTIVITY OF NOVEL NAFTOPIDIL ANALOGUE HUHS1015
Kuribayashi, Kozo
Ieki, Ryuji
Terada, Takayuki
Otsuki, Tai-Ichiro
Mikami, Koji
Kamiya, Hitomi
Masachika, Eriko
Tanaka, Akito
Nishizaki, Tomoyuki
Nakano, Takashi
RESPIROLOGY, 2015, 20 : 97 - 97
[2] In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects
Ilaria Zanellato
Carla Doriana Boidi
Guido Lingua
Pier-Giacomo Betta
Sara Orecchia
Elena Monti
Domenico Osella
Cancer Chemotherapy and Pharmacology, 2011, 67 : 265 - 273
[3] In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects
Zanellato, Ilaria
Boidi, Carla Doriana
Lingua, Guido
Betta, Pier-Giacomo
Orecchia, Sara
Monti, Elena
Osella, Domenico
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 265 - 273
[4] Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
Stish, B. J.
Oh, S.
Chen, H.
Dudek, A. Z.
Kratzke, R. A.
Vallera, D. A.
BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1114 - 1123
[5] Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
B J Stish
S Oh
H Chen
A Z Dudek
R A Kratzke
D A Vallera
British Journal of Cancer, 2009, 101 : 1114 - 1123
[6] Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
Morales, M. Lizeth Orozco M.
Rinaldi, Catherine
de Jong, Emma M.
Lansley, Sally
Lee, Y. C. Gary A.
Zemek, Rachael
Bosco, Anthony
Lake, Richard
Lesterhuis, W. Joost
PLOS ONE, 2023, 18 (05):
[7] Novel cucurbitacin analogue Cuc D exhibits potent anti-cancer activity in cervical cancer
Sikander, Mohammed
Bin Hafeez, Bilal
Halaweish, Fathi T.
Yallapu, Murali M.
Jaggi, Meena
Chauhan, Subhash C.
CANCER RESEARCH, 2016, 76
[8] Preclinical evaluation of ASP5286, a novel cyclophilin inhibitor with potent anti-HCV activity
Sawada, Masae
Tsujii, Eisaku
Morishita, Yoshihiko
Uchida, Masao
Katsumata, Kiyomitsu
Maki, Katsuyuki
Makino, Takuya
Yoshimura, Seiji
Yamanaka, Toshio
Lund, Garry
Kneteman, Norman M.
Tyrrell, D. J. Lorne
HEPATOLOGY, 2012, 56 : 1078A - 1078A
[9] Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity
Yang, Jingsong
Adam, Michael
Clemens, Jim
Creech, Katrina
Schneck, Jess
Pasikanti, Kishore
Jean-Luc Tran
Joglekar, Devika
Hopson, Chris
Pesiridis, Scott
Ramanjulu, Joshi
Lian, Yiqian
Adams, Jerry L.
Smothers, James
Hoos, Axel
CANCER RESEARCH, 2018, 78 (13)
[10] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
Beaulieu, Normand
Dupont, Isabelle
Hannah Nguyen
Carole, Beaulieu
Ste-Croix, Helene
Robert, Marie-France
Lefebvre, Sylvain
Lu, Ai Hua
Dubay, Maria
Rahil, Gabi
Wang, James
Mannion, Michael
Raeppel, Stephane
Saavedra, Oscar
Claridge, Stephen
Isakovic, Lubo
Zhan, Lijie
Gaudette, Frederic
Zhou, Nancy
Nantel, Miguel
Raeppel, Franck
Vaisburg, Arkadii
Besterman, Jeffrey
Maroun, Christiane
CANCER RESEARCH, 2009, 69

← 1 2 3 4 5 →